FORTRESS BIOTECH, INC. received a stock award from AVENUE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/17/2024ACC: 0001104659-24-048303
10% Owner
Since Dec 2022
+413.51K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
413.51K acquired
Non-Derivative Transactions1
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+413.51K
Price / share
—
Trade value
—
% of position
13.2%
4/16/2024
3.13M→3.55M
Total
Net shares
+413.51K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001 Direct | 4/16/2024 | A · Award | +413.51K | — | — | 13.2% | 3.13M | 3.55M |
| Total | +413.51K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported